Select publications

Cohen M et al. United States Food and Drug Administration drug approval summary: Gefitinib (ZD1839; Iressa) tablets. Clin Cancer Res 2004;10(4):1212-8. Abstract

de Andrade M et al. Environmental tobacco smoke exposure in women with lung cancer. Lung Cancer 2004;43:127-34. Abstract

Hanna NH et al. A Phase III study of pemetrexed vs docetaxel in patients with recurrent non-small cell lung cancer (NSCLC) who were previously treated with chemotherapy. Proc ASCO 2003;Abstract 2503.

Johnson D. Gefitinib (Iressa) trials in non-small cell lung cancer. Lung Cancer 2003;41(Suppl):23-8. Abstract

Kris M et al. Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: A randomized trial. JAMA 2003;290(16):2149-58. Abstract

Miller D et al. Association between self-reported environmental tobacco smoke exposure and lung cancer: Modification by GSTP1 polymorphism. Int J Cancer 2003;104:758-63. Abstract

Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 1995;311(7010):899-909. Abstract

Stanley KJ. The healing power of presence: Respite from the fear of abandonment. Oncol Nurs Forum 2002;29(6):935-40. Abstract